Jeffrey T L Smith

ZYME

Jeffrey T L Smith serves as officer: EVP & Chief Medical Officer at Zymeworks Inc. (ZYME). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$1.12M

Net Position

Net Seller

$1.12M

Companies Traded

ZYME

Active Period

Jan 2025 – Jan 2026

3 total trades

Most Recent

Sell ZYME

Jan 12, 2026 · $422.2K

Jeffrey T L Smith's Insider Trading at Zymeworks Inc. (ZYME)

Buys

0 · $0.00

Sells

3 · $1.12M

Total Shares Bought

Total Shares Sold

50,806

ZYME Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 12, 2026	Sell	18,620	$22.67	$422.2K	26,708
Jan 5, 2026	Sell	21,076	$25.10	$528.9K	18,352
Jan 6, 2025	Sell	11,110	$14.92	$165.8K	8,890

Related Insiders

Mark Hollywood

officer: EVP & Chief Operating Officer

ZYMESell · Jan 13, 2026

Kenneth Galbraith

director, officer: Chair & CEO

ZYMESell · Jan 12, 2026

Paul Andrew Moore

officer: Chief Scientific Officer

ZYMESell · Jan 12, 2026

Explore More Insider Trading Data

ZYME Insider Trading Activity

View all insider trades at Zymeworks Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity